Skip to main content
Clinical Trials/NCT04756791
NCT04756791
Withdrawn
Phase 4

Prospective Comparison of Single-Injection Serratus Anterior Plane Block With Ropivacaine Versus Local Infiltration of Anaesthetic After Breast Surgery

Universitair Ziekenhuis Brussel1 site in 1 country68 target enrollmentJune 16, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Mastectomy; Lymphedema
Sponsor
Universitair Ziekenhuis Brussel
Enrollment
68
Locations
1
Primary Endpoint
The use of opioids in the postoperative period
Status
Withdrawn
Last Updated
4 months ago

Overview

Brief Summary

To evaluate whether a serratus anterior plane block (SAPB) is more effective than a local infiltration anesthesia (LIA) with an equal dose and same anesthetic performed by the surgeon, as an adjuvant to treat postoperative pain after unilateral mastectomy.

Detailed Description

To evaluate whether a serratus anterior plane block (SAPB) is more effective than a local infiltration anesthesia (LIA) with an equal dose and same anesthetic performed by the surgeon, as an adjuvant to treat postoperative pain after unilateral mastectomy. Primary endpoint: the use of opioid's in the postoperative period. Secondary endpoint: Numerical Pain Rating Scale (NPRS) score recorded at the 2nd, 8th, 16th, 24th hour after surgery. 0 means no pain and 10 is the worst pain imaginable. In addition at the same time, we will look to the degree of arm mobilization where there will be 3 possible groups: 1. restricted, 2. fair mobilization and 3. free mobilization. There are 2 treatment arms: 1st arm is the standard therapy, namely the local infiltration anesthesia. 2nd arm is the experimental arm, namely the SAPB. Patients are randomised into each arm after screening.

Registry
clinicaltrials.gov
Start Date
June 16, 2021
End Date
December 31, 2024
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-80 years.
  • Provision of signed informed consent prior to any study-specific procedure.
  • Patients who come to preoperative anesthesia consultation for their scheduled unilat-eral mastectomy.

Exclusion Criteria

  • Age \>80 years
  • History of chronic pain or drug treatment abuse
  • Depression, psychiatric morbidity or mal-adaptive coping behavior
  • Neuropathy
  • Severe anxiety or other mental ailment, taking drugs affecting their capacity to assess pain
  • Chronic or acute skin infection of the lateral thorax
  • Hypersensitivity to ropivacaine
  • Severe hepatic or renal disease
  • Refuse to participate to the study
  • Pregnancy

Outcomes

Primary Outcomes

The use of opioids in the postoperative period

Time Frame: 24 hours

Patients receive a patient controlled intravenous anesthesia pump with morphine. We will be able to analyze the total amount of opioid requested by the patient.

Secondary Outcomes

  • Numerical Pain Rating Scale(24 hours)
  • Degree of arm mobilization(24 hours)

Study Sites (1)

Loading locations...

Similar Trials